Key result
This review outlines the diagnostic criteria, common clinical phenotypes, and current management strategies for heart failure with preserved ejection fraction.
This review outlines the diagnostic criteria, clinical phenotypes, and current management strategies for heart failure with preserved ejection fraction.
Aids HFpEF diagnosis and management in practice; leaves open phenotype-specific trials.
The clinical syndrome of heart failure with preserved ejection fraction (HFpEF) is unique in terms of etiologies, diagnostic criteria, costs, and treatment modalities when compared to heart failure with reduced ejection fraction. There is an emerging paradigm shift that recognizes the clinical syndrome of HFpEF and its various phenotypes. Understanding these HFpEF phenotypes is crucial to understanding the pathophysiology of HFpEF, which in turn can further guide our management strategies. This review outlines the diagnostic criteria, introduces the common clinical phenotypes, and discusses treatments currently utilized in practice for the management of HFpEF.
No takes yet. Share an insight, caveat, or question.
Soni et al. (2018) conducted a review in Heart failure with preserved ejection fraction (HFpEF). This review outlines the diagnostic criteria, common clinical phenotypes, and current management strategies for heart failure with preserved ejection fraction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: